Alton “Oliver” Sartor, M.D. (ONCL ’23), named a 2023 honorary member, Mayo Clinic Rochester

Alton “Oliver” Sartor, M.D. (ONCL ’23), Division of Medical Oncology at Mayo Clinic in Rochester, was named a 2023 honorary member of the American Society of Radiation Oncology (ASTRO). Dr. Sartor is the director of Radiopharmaceutical Trials at Mayo Clinic in Rochester, and formerly with Tulane University, where he served as medical director at the Tulane Cancer Center and the Laborde Professor of Medicine and Urology. ASTRO recognized him for outstanding contributions to the development of new therapies for prostate cancer, especially through his leadership of practice changing radiopharmaceutical clinical trials.